Substrate inhibitors and blockers of excitatory amino acid transporters in the treatment of neurodegeneration: critical considerations.
about
Why we should be vigilant: drug cytotoxicity observed with in vitro transporter inhibition studies.Probing for improved potency and in vivo bioavailability of excitatory amino acid transporter subtype 1 inhibitors UCPH-101 and UCPH-102: design, synthesis and pharmacological evaluation of substituted 7-biphenyl analogs.Trichostatin A enhances glutamate transporter GLT-1 mRNA levels in C6 glioma cells via neurosteroid-mediated cell differentiation.
P2860
Substrate inhibitors and blockers of excitatory amino acid transporters in the treatment of neurodegeneration: critical considerations.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Substrate inhibitors and block ...... tion: critical considerations.
@ast
Substrate inhibitors and block ...... tion: critical considerations.
@en
type
label
Substrate inhibitors and block ...... tion: critical considerations.
@ast
Substrate inhibitors and block ...... tion: critical considerations.
@en
prefLabel
Substrate inhibitors and block ...... tion: critical considerations.
@ast
Substrate inhibitors and block ...... tion: critical considerations.
@en
P2093
P50
P1476
Substrate inhibitors and block ...... tion: critical considerations.
@en
P2093
Elena Fumagalli
Giuseppe Campiani
Tiziana Mennini
P304
P356
10.1016/J.EJPHAR.2003.08.078
P407
P577
2003-10-01T00:00:00Z